Back
Jefferies Financial Group Vs. Keros Therapeutics Industry Stock Comparison
Buy
73
JEF
Jefferies Financial Group
Last Price:
45.47
Seasonality Move:
5.35%
Sell
25
KROS
Keros Therapeutics
Last Price:
45.02
Seasonality Move:
4.22%
Buy
73
Jefferies Financial Group (JEF)
is a Buy
Is Jefferies Financial Group a Buy, Sell or Hold?
- The current Jefferies Financial Group [JEF] share price is $46.04. The Score for JEF is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
- JEF is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
25
Keros Therapeutics (KROS)
is a Sell
Is Keros Therapeutics a Buy, Sell or Hold?
- The current Keros Therapeutics [KROS] share price is $45.65. The Score for KROS is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
- KROS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
JEF Stock Price Chart
What is Jefferies Financial Group's stock price today?
-
The Jefferies Financial Group share price today is $46.04
The current trend is moderately bullish and JEF is experiencing slight buying pressure.
KROS Stock Price Chart
What is Keros Therapeutics's stock price today?
-
The Keros Therapeutics share price today is $45.65
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KROS is experiencing slight selling pressure.
JEF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.13 | Buy |
Relative Strength Index (14 RSI): | 55.18 | Buy |
Chaikin Money Flow: | 86760 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (44.49 - 46.59) | Buy |
Bollinger Bands (100): | (41.76 - 45.82) | Buy |
KROS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.91 | Sell |
Relative Strength Index (14 RSI): | 36.74 | Sell |
Chaikin Money Flow: | -120480 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (46.18 - 50.06) | Sell |
Bollinger Bands (100): | (50.42 - 64.92) | Sell |
JEF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 45.43 | Buy |
20-day SMA: | 45.26 | Buy |
50-day SMA: | 44.96 | Buy |
200-day SMA: | 40.24 | Buy |
8-day EMA: | 45.62 | Buy |
20-day EMA: | 45.4 | Buy |
50-day EMA: | 44.94 | Buy |
200-day EMA: | 41.2 | Buy |
KROS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 46.5 | Sell |
20-day SMA: | 47.57 | Sell |
50-day SMA: | 52.43 | Sell |
200-day SMA: | 46.94 | Sell |
8-day EMA: | 46.46 | Sell |
20-day EMA: | 48 | Sell |
50-day EMA: | 51.59 | Sell |
200-day EMA: | 50.14 | Sell |
Jefferies Financial Group Earnings Growth & JEF Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.57 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.97 per share, and an increase next year of $1.38 per share.
Keros Therapeutics Earnings Growth & KROS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.03 per share, an increase this year of $0.35 per share, and a decrease next year of $0.39 per share.
Jefferies Financial Group Technical Analysis
Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Keros Therapeutics Technical Analysis
Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |